113 Botanicals and University of Sussex to bring controlled-release cannabis capsule and patches to UK
Scientists at 113 Botanicals and the University of Sussex are developing new formulations for cannabis-based medicines.
24 results for “university”
Scientists at 113 Botanicals and the University of Sussex are developing new formulations for cannabis-based medicines.
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
Clinicians, scientists and patients explored whether medical cannabis could help address longstanding inequalities in women’s health.
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
The death of Patrick Navarro has reignited concerns over discrimination in transplant eligibility.
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
It is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
The study found that 88% of participating officers knew little or nothing about the regulations before taking part in the training.
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
Findings highlighting the relationship between trauma, THC and paranoia have prompted calls for improved patient monitoring.
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? […]